Cambridge Investment Research Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19
-52.5%
30,8540.0%0.00%
Q2 2023$40
-25.9%
30,8540.0%0.00%
Q1 2023$54
-44.3%
30,8540.0%0.00%
-100.0%
Q4 2022$97
-99.9%
30,854
-0.2%
0.00%0.0%
Q3 2022$151,000
+18.0%
30,9120.0%0.00%0.0%
Q2 2022$128,000
-23.8%
30,912
+7.1%
0.00%0.0%
Q1 2022$168,000
-22.6%
28,862
-0.3%
0.00%0.0%
Q4 2021$217,000
-18.4%
28,962
-1.8%
0.00%0.0%
Q3 2021$266,000
-24.9%
29,504
-0.2%
0.00%
-50.0%
Q2 2021$354,000
-18.8%
29,573
-15.0%
0.00%0.0%
Q1 2021$436,000
-19.7%
34,8060.0%0.00%
-33.3%
Q4 2020$543,000
+91.9%
34,806
+16.2%
0.00%
+50.0%
Q3 2020$283,000
+5.2%
29,945
-0.3%
0.00%0.0%
Q2 2020$269,000
+40.8%
30,0450.0%0.00%0.0%
Q1 2020$191,000
-23.9%
30,0450.0%0.00%0.0%
Q4 2019$251,000
+21.3%
30,045
+31.1%
0.00%0.0%
Q3 2019$207,000
-1.4%
22,920
+17.6%
0.00%0.0%
Q2 2019$210,000
+14.1%
19,486
+1.0%
0.00%0.0%
Q1 2019$184,000
-1.6%
19,286
+18.3%
0.00%0.0%
Q4 2018$187,000
+2.7%
16,296
+52.1%
0.00%0.0%
Q3 2018$182,00010,7160.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders